| APC Minerals Limited (APC) ORDINARY FULLY PAID |
Materials |
$3 |
Proposed issue of securities - APC
|
27 Feb 2025 11:18AM |
$0.024 |
$0.009 |
fallen by
62.50%
|
|
| AIC Mines Limited (A1M) ORDINARY FULLY PAID |
Materials |
$190 |
Change of Director's Interest Notice - El-Raghy
|
27 Feb 2025 11:17AM |
$0.410 |
$0.330 |
fallen by
19.51%
|
|
| APC Minerals Limited (APC) ORDINARY FULLY PAID |
Materials |
$3 |
Proposed issue of securities - APC
|
27 Feb 2025 11:17AM |
$0.024 |
$0.009 |
fallen by
62.50%
|
|
| APC Minerals Limited (APC) ORDINARY FULLY PAID |
Materials |
$3 |
Investor Presentation
|
27 Feb 2025 11:17AM |
$0.024 |
$0.009 |
fallen by
62.50%
|
|
| APC Minerals Limited (APC) ORDINARY FULLY PAID |
Materials |
$3 |
Renounceable Issue
|
27 Feb 2025 11:17AM |
$0.024 |
$0.009 |
fallen by
62.50%
|
|
APC - Price-sensitive ASX Announcement
Full Release
Key Points
- APC undertaking a renounceable entitlement offer to raise A$1.93 million.
- Issue price set at A$0.011 per new share.
- Participants will receive one free attaching option for every three new shares subscribed.
- Funds will be primarily used for drilling at Laverton Downs Gold Project.
- The drilling campaign is set to begin in Q1 2024.
- APC settled $400,000 deferred consideration for Nexus Project with shares.
- Historical RAB drilling results include significant gold intercepts.
- Eligible shareholders must have a registered address in Australia or New Zealand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Globe International Limited (GLB) ORDINARY FULLY PAID |
Consumer Discretionary |
$128 |
Half Year Results FY25
|
27 Feb 2025 11:16AM |
$3.440 |
$3.080 |
fallen by
10.47%
|
|
GLB - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $95.3 million, down 12% on prior corresponding period.
- EBIT of $7.1 million, down 3% on prior corresponding period.
- EBIT margin improved to 7.5%.
- Net profit after tax of $4.8 million, down 3%.
- Declared interim dividend of $0.10 per share, up 11%.
- Strong cash flow with a net cash position of $17.3 million.
- Foundations for growth in revenue and profits are in place for FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$133 |
HY25 Results Presentation
|
27 Feb 2025 11:16AM |
$0.365 |
$0.293 |
fallen by
19.86%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Record HY25 GMV, up 86.0% on pcp, to US$446k ($677k).
- Completed media deals with major partners providing US$21.75m ($32.6m) in media capital.
- UK GMV hits $13m annualised run rate; US revenue grows 193%.
- Airtasker marketplaces to deliver double-digit revenue growth.
- Airtasker Australia generates sufficient cash to fund UK and US expansion.
- Accelerating momentum and continued growth trajectory in UK and US markets.
- Positive free cash flow in HY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Audeara Limited (AUA) ORDINARY FULLY PAID |
Consumer Discretionary |
$4 |
Appendix 4D & Half-Year Financial Report to 31 December 2024
|
27 Feb 2025 11:14AM |
$0.044 |
$0.023 |
fallen by
47.73%
|
|
AUA - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues increased by 129.45% to $1.80 million.
- Loss from ordinary activities after tax rose to $1.38 million.
- Cash at bank at period end was $1.69 million.
- Operational focus on efficiency and expenditure control.
- Launch of Audeara Buds and Auracast solutions.
- Expansion of presence in European market with reorders from France and Spain.
- Secured two-year contract extension with largest audiology retailer.
- Development of Clinico Sound Earbuds CS1 for Taiwan and China markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RMA Global Limited (RMY) ORDINARY FULLY PAID |
Communication Services |
$23 |
Half Yearly Report and Accounts
|
27 Feb 2025 11:12AM |
$0.036 |
$0.035 |
fallen by
2.78%
|
|
RMY - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for H1 FY25 reached $9.9 million, a 7% increase from H1 FY24.
- The company achieved its first-ever profitable half-year for underlying EBITDA.
- Recurring revenues increased by 4% to $9.6 million, driven by subscription and promoter fees.
- RMA's US operations grew by 6% to $2.4 million, supported by a strategic partnership with Realty One Group.
- New Zealand revenue showed strong momentum with a 28% increase to $1.1 million.
- Operating costs were reduced by 11%, reflecting improved operational efficiencies.
- The acquisition of Curated Social is expected to enhance RMA's market offering and drive future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bluglass Limited (BLG) ORDINARY FULLY PAID |
Information Technology |
$20 |
Appendix 4D and Financial Report 31 Dec 2024
|
27 Feb 2025 11:09AM |
$0.020 |
$0.010 |
fallen by
50%
|
|
BLG - Price-sensitive ASX Announcement
Full Release
Key Points
- Consolidated loss after tax of $5.72 million for the half-year ending 31 December 2024.
- Record revenue growth of 21% to $5.05 million.
- Increased operational expenses due to headcount growth and other factors.
- Focus on developing direct-to-market laser diode business for various high-value applications.
- Significant contracts secured, including a $2.9 million contract with North Carolina State University.
- Three US provisional patents filed for high-power tunable GaN lasers.
- Strong cash flow from operations with positive cash flows recorded.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Globe International Limited (GLB) ORDINARY FULLY PAID |
Consumer Discretionary |
$128 |
Appendix 4D - Half Year Accounts 27 February 2025
|
27 Feb 2025 11:09AM |
$3.440 |
$3.080 |
fallen by
10.47%
|
|
GLB - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax attributable to members is $4.76 million.
- Revenue from contracts with customers decreased by 11.7% to $95.29 million.
- EBIT margin improved to 7.5% from 6.8%.
- Interim dividend of 10 cents per share declared.
- Cash position increased to $24.6 million.
- Focus on strategic adjustments to brand mix for profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$1,101 |
Notification of cessation of securities - PDI
|
27 Feb 2025 11:06AM |
$0.343 |
$0.420 |
risen by
22.63%
|
|
| Claremont Global Fund (Hedged) (Managed Fund) (CGHE) CLAREMONT GLOBAL FUND (HEDGED) ACTIVE ETF |
Financials |
$73 |
Quarterly Portfolio Disclosure - December 2024
|
27 Feb 2025 11:01AM |
$1.785 |
$1.795 |
risen by
0.56%
|
|
| Claremont Global Fund (Managed Fund) (CGUN) CLAREMONT GLOBAL FUND ACTIVE ETF |
Financials |
$100 |
Quarterly Portfolio Disclosure - December 2024
|
27 Feb 2025 10:56AM |
$1.850 |
$1.800 |
fallen by
2.70%
|
|
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$133 |
HY25 Results Market Release
|
27 Feb 2025 10:53AM |
$0.365 |
$0.293 |
fallen by
19.86%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive free cash flow of $0.6m, an improvement of 105.3% on pcp
- Airtasker marketplaces revenue growth of 14.8% on pcp
- UK revenue growth of 99.8% on pcp
- US revenue growth of 193.3% on pcp
- $18.3m in cash and term deposits on balance sheet
- Global partnership with VCARB Formula One™ Team launched
- AI collaboration with OpenAI Operator launched
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bathurst Resources Limited (BRL) ORDINARY FULLY PAID |
Materials |
$175 |
Half Year Results Webcast Presentation
|
27 Feb 2025 10:52AM |
$0.740 |
$0.730 |
fallen by
1.35%
|
|
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$133 |
Half Yearly Report and Accounts
|
27 Feb 2025 10:48AM |
$0.365 |
$0.293 |
fallen by
19.86%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Airtasker reported a significant loss of $15.96 million for the half-year ended 31 December 2024.
- Statutory revenue increased by 10% to $25.66 million compared to the previous half-year.
- Marketplace revenue grew by 14.8% to $21.7 million, with a notable increase in booked tasks.
- Airtasker remains focused on expanding its marketing efforts and optimizing marketplace operations.
- The company aims to achieve positive free cash flow for the full financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$493 |
Half Year Results Presentation
|
27 Feb 2025 10:48AM |
$11.670 |
$9.830 |
fallen by
15.77%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues increased by 10.5% to $35.6 million.
- Profit before tax rose by 48.1% to $21.9 million.
- Profit after tax increased by 28.7% to $14.1 million.
- Established 93 North American Specialty Centers for SCENESSE®.
- Positive outcomes in clinical studies for vitiligo and variegate porphyria.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$493 |
Half Year Results Announcement
|
27 Feb 2025 10:47AM |
$11.670 |
$9.830 |
fallen by
15.77%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues increased by 10.5% to $43.3 million.
- Profit after tax rose to $14.1 million, up 28.7%.
- Underlying earnings before tax grew by 48.1% to $21.9 million.
- Net assets increased by 7% to $217.3 million.
- Clinuvel reported consecutive half-year profits since starting commercial operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$39 |
TNC Webinar Presentation
|
27 Feb 2025 10:46AM |
$0.385 |
$0.310 |
fallen by
19.48%
|
|
| Sims Limited (SGM) ORDINARY FULLY PAID |
Materials |
$2,966 |
Final Director's Interest Notice
|
27 Feb 2025 10:45AM |
$14.460 |
$15.350 |
risen by
6.15%
|
|
| Qualitas Real Estate Income Fund (QRI) ORDINARY UNITS FULLY PAID |
Financials |
$977 |
Appendix 4D and HY24 Financial Statements
|
27 Feb 2025 10:45AM |
$1.620 |
$1.605 |
fallen by
0.93%
|
|
| Asian Investment Corporation Limited (ANV) ORDINARY FULLY PAID |
- |
- |
Next Interest Payment Date
|
27 Feb 2025 10:44AM |
n/a |
n/a |
n/a
|
|
| Renu Energy Limited (RNE) ORDINARY FULLY PAID |
Utilities |
$0 |
Consolidation/Split - RNE
|
27 Feb 2025 10:43AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$493 |
Appendix 4D and Half Year Report
|
27 Feb 2025 10:42AM |
$11.670 |
$9.830 |
fallen by
15.77%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues increased by 21.1% to $43.29 million.
- Commercial sales and reimbursements rose by 10.5%.
- Interest income up 26.1% due to favorable cash reserve management.
- Net profit before tax rose by 48.1% to $21.93 million.
- Net profit after tax increased by 28.7% to $14.08 million.
- Cash reserves reached $198.2 million.
- Three strategic programs prioritized for development: vitiligo, ACTH, and porphyrias.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
